Edesa Biotech, Inc. (EDSA)
4.84
+0.08
(+1.68%)
USD |
NASDAQ |
Sep 03, 15:04
Edesa Biotech Price : 4.84 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 4.81 | 5.053 | 4.76 | 4.76 | 29813.00 |
| Sep 01, 2026 | 4.78 | 5.010 | 4.61 | 4.78 | 24180.00 |
| Aug 31, 2026 | 4.70 | 4.94 | 4.45 | 4.735 | 91748.00 |
| Aug 28, 2026 | 4.65 | 4.926 | 4.502 | 4.62 | 70656.00 |
| Aug 27, 2026 | 4.97 | 4.978 | 4.60 | 4.60 | 81257.00 |
| Aug 26, 2026 | 4.50 | 5.10 | 4.40 | 4.94 | 235301.0 |
| Aug 25, 2026 | 4.39 | 4.75 | 4.28 | 4.45 | 112048.0 |
| Aug 24, 2026 | 4.45 | 4.60 | 4.12 | 4.40 | 101555.0 |
| Aug 21, 2026 | 4.50 | 4.95 | 4.17 | 4.43 | 156244.0 |
| Aug 20, 2026 | 5.19 | 6.00 | 4.50 | 4.76 | 391910.0 |
| Aug 19, 2026 | 5.71 | 6.00 | 5.61 | 5.75 | 119833.0 |
| Aug 18, 2026 | 5.60 | 6.30 | 5.60 | 5.71 | 49134.00 |
| Aug 17, 2026 | 5.36 | 6.67 | 5.36 | 5.65 | 123367.0 |
| Aug 14, 2026 | 5.69 | 5.89 | 5.35 | 5.35 | 46136.00 |
| Aug 13, 2026 | 5.37 | 5.72 | 5.30 | 5.43 | 35275.00 |
| Aug 12, 2026 | 5.46 | 5.56 | 5.30 | 5.30 | 26305.00 |
| Aug 11, 2026 | 5.31 | 5.61 | 5.25 | 5.52 | 34111.00 |
| Aug 10, 2026 | 5.37 | 5.700 | 5.17 | 5.24 | 37072.00 |
| Aug 07, 2026 | 5.10 | 5.78 | 5.10 | 5.27 | 54688.00 |
| Aug 06, 2026 | 5.11 | 5.300 | 5.03 | 5.05 | 21935.00 |
| Aug 05, 2026 | 5.30 | 5.822 | 5.03 | 5.17 | 31374.00 |
| Aug 04, 2026 | 5.09 | 5.64 | 5.09 | 5.36 | 36156.00 |
| Aug 03, 2026 | 5.09 | 5.305 | 4.83 | 5.23 | 39138.00 |
| Jul 31, 2026 | 5.26 | 5.29 | 4.77 | 5.11 | 58626.00 |
| Jul 30, 2026 | 5.29 | 5.500 | 4.92 | 5.25 | 76298.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ProMIS Neurosciences, Inc. | 13.01 |
| Arrowhead Pharmaceuticals, Inc. | 85.84 |
| Oncolytics Biotech, Inc. | 0.855 |
| Sangamo Therapeutics, Inc. | 0.171 |
| Sarepta Therapeutics, Inc. | 23.02 |
Price Related Metrics
| PEG Ratio | -0.1046 |
| Price to Book Value | 116.85 |
| Earnings Yield | -34.95% |
| Market Cap | 46.62M |
| PEGY Ratio | -0.1046 |